Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 3 9Phase NA 6Phase 2/3 5Phase 1 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 1Breast 1

Conditions

Tuberous Sclerosis 1Smith-Magenis Syndrome 1Relapsed Malignant Solid Tumor 1Parasomnias 1Breast Neoplasms 1Autism Spectrum Disorder 1Angelman Syndrome 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Melatonin × Clear all
NCT01858155 2019-01-31

Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors

C17 Council

Phase 1 Completed
9 enrolled
Other solid neoplasm

Relapsed Malignant Solid Tumor

NCT01903681 2014-04-04

Assessment of the Pharmacokinetics of CircadinĀ® in Children With Neurodevelopmental Disorders and Sleep Disturbances

Neurim Pharmaceuticals Ltd.

Phase 1 Completed
16 enrolled

Autism Spectrum Disorder, Tuberous Sclerosis, Angelman Syndrome, Parasomnias, Smith-Magenis Syndrome

NCT00506064 2012-12-05

Melatonin Postoperative Sleep Study in Breast Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Terminated
4 enrolled 2 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔